Dow Down 0.02% Nasdaq Up 0.07%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
4.23 Nov 25, 4:00PM EST
Prev Close:4.23
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:24.00
Beta:1.47
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:4.01 - 19.11
Volume:0
Avg Vol (3m):249,925
Market Cap:93.58M
P/E (ttm):N/A
EPS (ttm):-0.77
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALT

Comparison

Symbol% ChgMkt Cap
GALT 0.00%93.58M
MNTA598.96M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.90
Quarterly EPS Est (Dec-14) :-0.22
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback